EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

ISG15 links type I interferon pathway to cardiovascular risk in systemic lupus erythematosus

Chao Wang, Xinxin Liu, Xingyu Fu, Xiaochen Yu, Min Li, Xiuru Guan

Clinical and Experimental Medicine · 10.08.2026 · 26 (1)

DOI: 10.1007/s10238-026-02275-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Medicine, online erschienen am 10.08.2026. Verfasst von Chao Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Diagnostics, First Affiliated Hospital of Harbin Medical University, 23 Youzheng Street, NanGang, Harbin, 150001, Heilongjia…. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Cytokines, Ubiquitins, Interferon Type I. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The fundamental research funds for the provincial universities in heilongjiang province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients with systemic lupus erythematosus (SLE) have significantly increased cardiovascular risk, and atherosclerosis (AS) is a major cause of long-term mortality. However, whether SLE-specific immune dysregulation drives accelerated AS remains unclear. This study explored the role of interferon-stimulated gene 15 (ISG15) in SLE-associated AS. We first characterized the disease manifestations, then identified disease characteristics at the proteomic and transcriptomic levels via multi-omics analysis of a pristane-induced SLE-ApoE-/- mouse model and integrated analysis of SLE and AS datasets. We found ISG15 was uniquely elevated across atherosclerotic plaque types and correlated with cardiovascular events, with robust interferon-alpha response activation in SLE mice. Further, ISG15 colocalized with CD68⁺ macrophages in plaques, and extended analysis showed it was highly expressed in peripheral blood monocytes of SLE patients. Clinically, ISG15⁺ monocyte proportion was significantly higher in SLE patients with AS, outperforming conventional cardiovascular risk scores and serving as an independent predictor. In conclusion, ISG15 is a critical effector linking SLE immune dysregulation to accelerated AS, and ISG15⁺ monocyte proportion is a promising biomarker for cardiovascular risk stratification in SLE patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, SystemicCytokinesUbiquitinsInterferon Type IAtherosclerosisCardiovascular DiseasesAnimalsHumansFemaleMiceDisease Models, AnimalMaleAdultBiomarkersMice, KnockoutMonocytesGene Expression ProfilingMiddle Aged

Stichwörter der Autor:innen

AtherosclerosisBiomarkerISG15Systemic lupus erythematosusType I interferon

Substanzen

CytokinesUbiquitinsISG15 protein, humanInterferon Type IG1p2 protein, mouseBiomarkers

Autor:innen und Institutionen

  • Department of Laboratory Diagnostics, First Affiliated Hospital of Harbin Medical University, 23 Youzheng Street, NanGang, Harbin, 150001, Heilongjiang, P.R. China.
  • Department of Laboratory Diagnostics, First Affiliated Hospital of Harbin Medical University, 23 Youzheng Street, NanGang, Harbin, 150001, Heilongjiang, P.R. China. gxr0451@sina.com.

Förderung

  • The fundamental research funds for the provincial universities in heilongjiang province

Zitieren

APA

Wang, C., Liu, X., Fu, X., Yu, X., Li, M., & Guan, X. (2026). ISG15 links type I interferon pathway to cardiovascular risk in systemic lupus erythematosus. Clinical and Experimental Medicine, 26(1). https://doi.org/10.1007/s10238-026-02275-4

Vancouver

Wang C, Liu X, Fu X, Yu X, Li M, Guan X. ISG15 links type I interferon pathway to cardiovascular risk in systemic lupus erythematosus. Clinical and Experimental Medicine. 2026;26(1). doi:10.1007/s10238-026-02275-4

BibTeX
@article{Wang2026,
  author = {Wang, Chao and Liu, Xinxin and Fu, Xingyu and Yu, Xiaochen and Li, Min and Guan, Xiuru},
  title = {ISG15 links type I interferon pathway to cardiovascular risk in systemic lupus erythematosus},
  journal = {Clinical and Experimental Medicine},
  year = {2026},
  volume = {26},
  number = {1},
  doi = {10.1007/s10238-026-02275-4}
}
Kostenlos starten →